D
Douglas E. Wood
Researcher at University of Washington
Publications - 202
Citations - 16763
Douglas E. Wood is an academic researcher from University of Washington. The author has contributed to research in topics: Lung cancer & Lung volume reduction surgery. The author has an hindex of 55, co-authored 191 publications receiving 14504 citations. Previous affiliations of Douglas E. Wood include Seattle Cancer Care Alliance & Fred Hutchinson Cancer Research Center.
Papers
More filters
Journal ArticleDOI
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema.
Alfred P. Fishman,Fernando J. Martinez,Keith S. Naunheim,Steven Piantadosi,Robert A. Wise,Andrew L. Ries,Gail Weinmann,Douglas E. Wood +7 more
TL;DR: Overall, lung-volume-reduction surgery increases the chance of improved exercise capacity but does not confer a survival advantage over medical therapy, although it does yield a survival advantages for patients with both predominantly upper-lobe emphysema and low base-line exercise capacity.
Journal ArticleDOI
Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review
Peter B. Bach,Joshua N. Mirkin,Thomas K. Oliver,Christopher G. Azzoli,Donald A. Berry,Otis W. Brawley,Tim Byers,Graham A. Colditz,Michael K. Gould,James R. Jett,Anita L. Sabichi,Rebecca Smith-Bindman,Douglas E. Wood,Amir Qaseem,Frank C. Detterbeck +14 more
TL;DR: Low-dose computed tomography screening may benefit individuals at an increased risk for lung cancer, but uncertainty exists about the potential harms of screening and the generalizability of results.
Journal ArticleDOI
Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology
David S. Ettinger,Douglas E. Wood,Dara L. Aisner,Wallace Akerley,Jessica Bauman,Lucian R. Chirieac,Thomas A. D'Amico,Malcolm M. DeCamp,Thomas J. Dilling,Michael C. Dobelbower,Robert C. Doebele,Ramaswamy Govindan,Matthew A. Gubens,Mark Hennon,Leora Horn,Ritsuko Komaki,Rudy P. Lackner,Michael Lanuti,Ticiana A. Leal,Leah J. Leisch,Rogerio Lilenbaum,Jules Lin,Billy W. Loo,Renato Martins,Gregory A. Otterson,Karen L. Reckamp,Gregory J. Riely,Steven E. Schild,Theresa A. Shapiro,James P. Stevenson,Scott J. Swanson,Kurt Tauer,Stephen C. Yang,Kristina M. Gregory,Miranda Hughes +34 more
TL;DR: This selection from the NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) focuses on targeted therapies and immunotherapies for metastatic NSCLC, because therapeutic recommendations are rapidly changing for metastasis disease.
Journal ArticleDOI
Non–Small Cell Lung Cancer
David S. Ettinger,Wallace Akerley,Gerold Bepler,Andrew C. Chang,Richard T. Cheney,Lucian R. Chirieac,Thomas A. D'Amico,Todd L. Demmy,Steven J. Feigenberg,Robert A. Figlin,Ramaswamy Govindan,Frederic W. Grannis,Thierry Jahan,Mohammad Jahanzeb,Anne Kessinger,Ritsuko Komaki,Mark G. Kris,Corey J. Langer,Quynh-Thu Le,Renato G. Martins,Gregory A. Otterson,Jyoti D. Patel,Francisco Robert,David J. Sugarbaker,Douglas E. Wood +24 more
TL;DR: In 2010, approximately 222,520 new cases of lung or bronchial cancer will be diagnosed in the USA, and 157,300 patients are expected to die of this disease as discussed by the authors.
Journal ArticleDOI
Non-small cell lung cancer: Clinical practice guidelines in oncology
David S. Ettinger,Wallace Akerley,Gerold Bepler,Matthew G. Blum,Andrew C. Chang,Richard T. Cheney,Lucian R. Chirieac,Thomas A. D'Amico,Todd L. Demmy,Apar Kishor Ganti,Ramaswamy Govindan,Frederic W. Grannis,Thierry Jahan,Mohammad Jahanzeb,David H. Johnson,Anne Kessinger,Ritsuko Komaki,Feng Ming Kong,Mark G. Kris,Lee M. Krug,Quynh-Thu Le,Inga T. Lennes,Renato Martins,Janis P. O'Malley,Raymond U. Osarogiagbon,Gregory A. Otterson,Jyoti D. Patel,Katherine M.W. Pisters,Karen L. Reckamp,Gregory J. Riely,Eric M. Rohren,George R. Simon,Scott J. Swanson,Douglas E. Wood,Stephen C. Yang +34 more
TL;DR: The NCCN Clinical Practice Guidelines in Oncology for Small Cell Lung Cancer (SCLC) focus on extensive-stage SCLC because it occurs more frequently than limited-stage disease as discussed by the authors.